Laxitin Susp is a precisely formulated pharmaceutical suspension engineered for industrial-scale production. The formulation integrates Liquid Parafin IP (1.25ml), Milk of Magnesa IP (3.75ml), and Sodium Picosulphate (3.33mg) in a stable, homogeneous suspension. The combination of these excipients ensures optimal physicochemical properties, including suspension stability, compatibility with packaging materials, and uniform dispersion of active ingredients. The formulation’s design prioritizes ease of manufacturing, consistent dosing accuracy, and adherence to pharmaceutical standards. Sodium Picosulphate, a key active component, is suspended in a blend of liquid paraffin and magnesium hydroxide, which enhances its solubility and bioavailability. The suspension’s viscosity and particle size distribution are carefully controlled during formulation to ensure uniformity across batches. Manufacturing processes focus on maintaining the integrity of the active pharmaceutical ingredient (API) while ensuring compliance with Good Manufacturing Practice (GMP) guidelines.
Manufacturing Capability
Our manufacturing infrastructure is designed to meet the demands of large-scale pharmaceutical production. The facility is equipped with advanced sterile processing capabilities, including ISO Class 7 cleanrooms, to ensure contamination-free production of Laxitin Susp. State-of-the-art equipment such as high-speed mixers, homogenizers, and filtration systems enable precise blending and dispersion of the suspension. The manufacturing process adheres to strict GMP standards, with continuous monitoring of critical parameters such as temperature, pH, and particle size. Production scalability is achieved through modular manufacturing units that can accommodate varying batch sizes without compromising quality. The facility’s quality systems include real-time data acquisition, automated process controls, and comprehensive documentation to ensure traceability and compliance.
Available Strengths and Packaging
Laxitin Susp is formulated with a standardized strength of Liquid Parafin IP (1.25ml), Milk of Magnesa IP (3.75ml), and Sodium Picosulphate (3.33mg) in a 170ml suspension. The fixed composition ensures consistency in dosing and formulation, making it ideal for bulk supply and global distribution. The 170ml packaging size is optimized for efficient storage, transportation, and commercial scalability.
Contract Manufacturing / Third Party Manufacturing
As a trusted manufacturer, we offer comprehensive contract manufacturing and third-party production services tailored to pharmaceutical buyers. Our capabilities include private label manufacturing, where we produce Laxitin Susp under a client’s brand name, ensuring full customization of packaging, labeling, and quality control. We also provide flexible contract manufacturing solutions for clients seeking to outsource production while maintaining compliance with global regulatory standards. Our team collaborates closely with clients to align formulations, packaging, and production schedules with market-specific requirements. Whether you need small-scale trials or large-volume production, our scalable infrastructure and expertise in pharmaceutical manufacturing ensure timely delivery of high-quality products.
Quality Assurance
Our quality assurance systems are built on rigorous analytical validation and batch testing protocols. Every batch of Laxitin Susp undergoes comprehensive testing for pH, viscosity, particle size distribution, and active ingredient content using validated methods such as HPLC and UV spectrophotometry. Microbial contamination testing, endotoxin analysis, and stability studies are conducted to ensure product safety and shelf-life compliance. All quality control data is documented and traceable, adhering to ICH and FDA guidelines. Our quality management system (QMS) is ISO 9001-certified, ensuring continuous improvement in manufacturing processes.
Regulatory Compliance
Laxitin Susp is manufactured in full compliance with global regulatory frameworks, including GMP, WHO guidelines, and ISO standards. Our facility meets the requirements of the FDA, EMA, and MHRA, ensuring products are suitable for export to regulated markets. All documentation, including batch records, certificates of analysis (CoA), and stability data, is prepared in accordance with ICH Q7 and ICH Q10 guidelines. We maintain regulatory compliance through regular audits, validation of critical processes, and adherence to Good Distribution Practice (GDP) standards.
Global Supply Capability
We have a robust international distribution network and the capacity to supply Laxitin Susp in bulk to global markets. Our logistics partners ensure reliable and timely delivery to destinations worldwide, with options for temperature-controlled shipping and customs compliance. The 170ml packaging is designed for efficient bulk storage and transportation, reducing logistical complexities. Our supply chain is optimized for scalability, with the ability to meet large-volume orders without compromising quality or delivery timelines.
Why Choose Us
Pharmaceutical distributors, exporters, and contract manufacturing partners choose us for our expertise in bulk manufacturing, regulatory compliance, and global supply capabilities. Our commitment to GMP standards, advanced infrastructure, and quality assurance ensures consistent product performance. We offer tailored solutions to meet the unique needs of clients, from private labeling to large-scale production. With a proven track record in the pharmaceutical industry, we provide reliable, cost-effective services that align with global market demands.
Bulk Supply Inquiry
For bulk supply inquiries, contact our dedicated team at info@delwishealthcare.com to discuss production schedules, packaging options, and export logistics.
FAQs
What is the composition of Laxitin Susp?
Laxitin Susp contains Liquid Parafin IP (1.25ml), Milk of Magnesa IP (3.75ml), and Sodium Picosulphate (3.33mg) in a 170ml suspension.
Is Laxitin Susp suitable for bulk manufacturing?
Yes, the formulation is designed for scalable production, ensuring consistency and efficiency in large-volume manufacturing.
What packaging options are available for Laxitin Susp?
The product is available in 170ml packaging, optimized for bulk storage and global distribution.
Does your facility comply with GMP standards?
Yes, our manufacturing processes adhere to strict GMP guidelines, with continuous monitoring and validation.
Can Laxitin Susp be produced under private labeling?
Yes, we offer private label manufacturing services, allowing clients to brand the product under their own name.
What quality control measures are in place for Laxitin Susp?
Each batch undergoes rigorous testing for pH, viscosity, particle size, and active ingredient content, with full documentation for traceability.
Is Laxitin Susp compliant with WHO and ISO standards?
Yes, our production processes meet WHO guidelines and ISO certifications, ensuring global market readiness.
How does your company support export capabilities?
We provide customs-compliant packaging, temperature-controlled shipping, and logistics partnerships to ensure seamless international distribution.
Can you accommodate large-volume orders for Laxitin Susp?
Yes, our scalable infrastructure is designed to handle bulk orders without compromising quality or delivery timelines.
How can I inquire about bulk supply of Laxitin Susp?
Contact our team at **info@delwishealthcare.com** for detailed information on bulk supply, pricing, and production schedules.
.webp&w=3840&q=75 "Dicaine Gel")